Scinovex
review Open AccessTop 10% cited

Systematic review: the model for end‐stage liver disease – should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis?

Alimentary Pharmacology & Therapeutics · 2005 · Vol. 22(11-12) · pp. 1079–1089
Εvangelos CholongitasGeorge PapatheodoridisMarcello VangeliN. TerreniDavid PatchAndrew K. Burroughs

Abstract

Based on current literature, model for end-stage liver disease score does not perform better than Child-Turcotte-Pugh score in non-transplant settings. Modified Child-Turcotte-Pugh and model for end-stage liver disease scores need further evaluation.

Liver Disease and TransplantationLiver Disease Diagnosis and TreatmentOrgan Transplantation Techniques and OutcomesMedicineModel for End-Stage Liver DiseaseLiver diseaseLiver transplantationCirrhosisInternal medicineGastroenterologyAscitesTransjugular intrahepatic portosystemic shuntHepatic encephalopathy

MeSH terms

AscitesEsophageal and Gastric VaricesGastrointestinal HemorrhageHepatic EncephalopathyHumansLiver CirrhosisPrognosisSeverity of Illness IndexLiver Failure
Citations
419
FWCI
2.64
field-weighted impact
References
57
Percentile
90%
vs. same field & year
Citations per year
Cited by
The model for end-stage liver disease (MELD)
Hepatology · 2007 · 1,646 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Systematic review: the model for end‐stage liver disease – should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis? · Scinovex